Cargando…
Use of secondary prevention pharmacotherapy after first myocardial infarction in patients with diabetes mellitus
BACKGROUND: Despite recommended pharmacotherapies the use of secondary prevention therapy after myocardial infarction (MI) remains suboptimal. Patients with diabetes mellitus (DM) have worse prognosis after MI compared to patients without DM and aggressive secondary prevention pharmacotherapy in thi...
Autores principales: | Jørgensen, Casper H, Gislason, Gunnar H, Ahlehoff, Ole, Andersson, Charlotte, Torp-Pedersen, Christian, Hansen, Peter R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3897983/ https://www.ncbi.nlm.nih.gov/pubmed/24406095 http://dx.doi.org/10.1186/1471-2261-14-4 |
Ejemplares similares
-
Effects of oral glucose-lowering drugs on long term outcomes in patients with diabetes mellitus following myocardial infarction not treated with emergent percutaneous coronary intervention - a retrospective nationwide cohort study
por: Jørgensen, Casper H, et al.
Publicado: (2010) -
Hormone Replacement Therapy and Risk of New-Onset Atrial Fibrillation after Myocardial Infarction - A Nationwide Cohort Study
por: Bretler, Ditte-Marie, et al.
Publicado: (2012) -
Discontinuation of hormone replacement therapy after myocardial infarction and short term risk of adverse cardiovascular events: nationwide cohort study
por: Bretler, Ditte-Marie, et al.
Publicado: (2012) -
Disease Activity in Inflammatory Bowel Disease Is Associated with Increased Risk of Myocardial Infarction, Stroke and Cardiovascular Death – A Danish Nationwide Cohort Study
por: Kristensen, Søren Lund, et al.
Publicado: (2013) -
Correction: Disease Activity in Inflammatory Bowel Disease Is Associated with Increased Risk of Myocardial Infarction, Stroke and Cardiovascular Death – A Danish Nationwide Cohort Study
por: Kristensen, Søren Lund, et al.
Publicado: (2013)